Document:

Exhibit 4.20

    

    

    
      AMENDMENT TO 

      EMPLOYMENT AGREEMENT

       

      The Employment Agreement by and between BeyondSpring Pharmaceuticals, Inc. (the “Company”) and Richard Daly (the “Employee”) dated as of June 8, 2018 (the “Agreement”) is hereby amended , effective as of September 24, 2019, as follows:

       

      
        
          	1.	
                  The final sentence of Section 3.a. of the Agreement is hereby deleted in its entirety and replaced with the following:

                

        

      

       

      “The Company hereby covenants and agrees to perform a comprehensive compensation review of all executives no later than December 31, 2019, and to implement  a  competitive, broad-based compensation increase program in connection therewith that includes Employee, such program to be made retroactive to August 1, 2019.”

       

      
        
          	2.	
                  Except as explicitly set forth herein, the Agreement will remain in full force and effect.

                

        

      

      

      

      IN WITNESS WHEREOF, the parties have executed this amendment effective as of the date written above.

       

      	 	
              BEYONDSPRING PHARMACEUTICALS, INC.

            
	 	 	 
	 	
              By:  

              

            	
              /s/ Lan Huang

            
	 	 	 
	 	
              Its:  

              

            	
              CEO

            

      

      

      	 	
              EMPLOYEE

            
	 	 
	 	
              /s/ Richard Daly

            
	 	
              Richard DalyExhibit 4.21

  

  

  
    SECOND AMENDMENT TO EMPLOYMENT AGREEMENT

     

    This Second Amendment to Employment Agreement (this “Amendment”), dated this12/26/19, is entered into by and between BeyondSpring Pharmaceuticals, Inc. (the “Company”) and Mr. Richard
      Daly (“Employee”).

     

    RECITALS

     

    WHEREAS, the Company and Employee are parties to that Employment Agreement, dated as of June 8, 2018, as amended by
      that Amendment, dated as of September 24, 2019 (the “Employment Agreement”); and

     

    WHEREAS, the parties wish to amend the terms of the Employment Agreement, as set forth herein, effective as of August
      1, 2019.

     

    NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the
      receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

     

    
      
        
          1.            Section 3(a). Section 3(a) is hereby amended and restated in its entirely as follows:

        

      

    

     

    Employee shall be paid a salary of $430,000 annually, payable in accordance with the regular payroll practices of the Company. In addition to the base salary, Employee will be eligible to earn an the annual bonus of up to
      45% of annual salary, depending on meeting all pre-specified milestones.

     

    
      
        
          2.            Section 3(b). Section 3(b) is hereby amended and restated in its entirety as follows:

        

      

    

     

    In addition to the base salary and any annual bonus payable pursuant to Section 3.a., Employee shall be eligible to receive the incentive payments set forth on Annex B hereto. If earned, any such
      amounts shall be paid either in cash or, at the election of Employee (subject to prior approval of the Board of Directors of the Company and compliance with applicable securities law), fully vested shares of the Company’s capital stock having a
      valuation equal to such amount (if available for issuance).

     

    
      
        3.            Annex B, Section 1. The last sentence of Section 1 of Annex B of the Agreement is hereby amended and restated as follows:

      

    

     

    Payments in respect of milestones described in Section 1 above shall be made only if Employee is employed at the time the milestone is achieved, and, if earned, shall be paid in accordance with the
      regular payroll practices of the Company within (30) days following determination of achievement of the applicable milestone.

     

    

    
      
        

    

    4.           Annex B, Section 2. The last sentence of Section 2 of Annex B is hereby amended and restated as follows:

     

    Payments in respect of milestones described in Section 2 above shall be determined as follows: in the event that the Company achieves any such milestone, the Company will pay the Employee the
      Applicable Amount within thirty (30) days following the achievement of the applicable milestone, in accordance with the regular payroll practices of the Company.

     

    5.           Continuation of Employment Agreement. Except as otherwise expressly provided herein, all of the terms and provisions of the Employment Agreement shall remain in full force and effect and this
      Employment Amendment shall not amend or modify any other rights, powers, duties, or obligations of any party to the Employment Agreement.

    

    

    6.           Complete Agreement. This Amendment and the Employment Agreement contain the entire agreement between the parties hereto with respect to the matters contained herein and supersedes and replaces any
      prior agreement between the parties with respect to the matters set forth in this Amendment.

    

    

    7.           Counterparts. This Amendment may be executed in any number of counterparts and any such counterparts may be transmitted by electronic transmission, and each of such counterparts, whether an
      original or an electronic or ".pdf" of an original, shall be deemed to be an original and all of such counterparts together shall constitute a single agreement.

    

    

    IN WITNESS WHEREOF, the parties hereto have executed this Amendment, on the date first set forth above.

    

    

    	
            EMPLOYEE

          	 	
            
              BEYONDSPRING PHARMACEUTICALS, INC.

            

          	 
	 	 	 	 
	
            /s/ Richard Daly

          	 	
            /s/ Lan Huang

          	 
	
            Richard Daly

          	 	 	 	 
	
            

            

          	 	
            By:

          	
            Lan Huang, PhD

          	 
	 	 	 	 	 
	 	 	
            Its:

          	
            CEOExhibit 4.22

      

       

        

      
        
          	
                   

                	
                  
                    

                  

                
	 	 
	 	
                  Lan Huang, Ph.D. 

                  

                  Chief Executive Officer 

                  

                  
                    BeyondSpring Pharmaceuticals, Inc.

                    
                      28 Liberty Street, 39th Floor

                    

                  

                  New York, NY 10005

                  Tel: 646.305.6387 

                  

                

           

          

          
            January 1, 2020

            

            

            
              	
                      RE:

                    	
                      ANNUAL SALARY RAISE

                    

            

            Lan Huang

            

            

            Dear Lan,

             

            We are pleased to offer you an increase in your annual base salary from $300,000.00 to $520,000.00. In addition, we are increasing your annual bonus opportunity from 30% of annual salary to 50% of annual salary
              (otherwise subject to the same terms and conditions in your Employment Agreement (defined below). This change will take effect on January 1, 2020.

             

            Except as expressly provided in this letter, your employment agreement with BeyondSpring Pharmaceuticals, Inc., dated as of April 1, 2016, as amended by that amendment dated as of November 10, 2016, (your
              “Employment Agreement”) shall remain in full force and effect.

             

            Again, congratulations on your achievement and we wish you all the very best in the coming years. Please let me know if you have any questions regarding your new compensation package.

             

            
              Sincerely,

            

             

            

          

          
            	
                    /s/ Lan Huang

                  	
                     

                  
	
                    Lan Huang, Ph.D.

                  	
                     

                  
	
                     

                  	
                     

                  
	
                    Agreed:

                  	 
	 	 
	
                    
                      /s/ Lan Huang

                    

                  	
                     

                  
	
                    
                      Lan Huang, Ph.D.Exhibit 4.23

    

     

      

    
      	
               

            	
              
                

              

            
	 	 
	 	
              Lan Huang, Ph.D. 

              

              Chief Executive Officer 

              

              
                BeyondSpring Pharmaceuticals, Inc.

                
                  28 Liberty Street, 39th Floor

                

              

              New York, NY 10005 

              Tel: 646.305.6387 

              

            

    

    
      

      

      January 1, 2020

       

      
        	
                RE:

              	
                ANNUAL SALARY RAISE

              

      

      Edward Dongheng Liu

      

      

      Dear Edward,

      

      

      We are pleased to offer you an increase in your annual base salary from $300,000.00

          to $430,000.00. In addition, we are increasing your annual bonus opportunity to 45% of annual salary (otherwise subject to the
        same terms and conditions in your Employment Agreement (defined below). This change will take effect on January 1, 2020.

       

      Except as expressly provided in this letter, your employment agreement with BeyondSpring Pharmaceuticals, Inc., dated as of March 26, 2018, (your “Employment Agreement”) shall remain in full force and effect.

      

      

      
        Again, congratulations on your achievement and we wish you all the very best in the coming years. Please let me know if you have any questions regarding your new compensation package.

      

       

      Sincerely,

      

      

      
        
          	
                  /s/ Lan Huang

                	
                   

                
	
                  Lan Huang, Ph.D.

                	
                   

                
	
                   

                	
                   

                
	
                  Agreed:

                	 
	 	 
	
                  /s/ Edward Dongheng Liu

                	
                   

                
	
                  Edward Dongheng Liu

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}]]